Micro-X Limited (MX1.AX)
AUD 0.07
(10.0%)
AUD 0.07
(10.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 5.73 Million AUD | 180.71% |
| 2023 | -7.1 Million AUD | 42.33% |
| 2022 | -12.32 Million AUD | 4.91% |
| 2021 | -12.96 Million AUD | -68.51% |
| 2020 | -7.69 Million AUD | -67.73% |
| 2019 | -4.58 Million AUD | 28.79% |
| 2018 | -6.44 Million AUD | 55.95% |
| 2017 | -14.62 Million AUD | 12.92% |
| 2016 | -16.79 Million AUD | -23419.44% |
| 2015 | 72 Thousand AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -3.76 Million AUD | 0.0% |
| 2024 Q4 | 3.1 Million AUD | 0.0% |
| 2024 FY | -8.71 Million AUD | -22.64% |
| 2023 Q4 | -5.26 Million AUD | 0.0% |
| 2023 Q2 | -1.84 Million AUD | 0.0% |
| 2023 FY | -7.1 Million AUD | 42.33% |
| 2022 Q2 | -8.15 Million AUD | 0.0% |
| 2022 FY | -12.32 Million AUD | 4.91% |
| 2022 Q4 | -4.17 Million AUD | 0.0% |
| 2021 Q2 | -4.9 Million AUD | 0.0% |
| 2021 Q4 | -8.05 Million AUD | 0.0% |
| 2021 FY | -12.96 Million AUD | -68.51% |
| 2020 Q4 | -4.5 Million AUD | 0.0% |
| 2020 Q2 | -3.18 Million AUD | 0.0% |
| 2020 FY | -7.69 Million AUD | -67.73% |
| 2019 FY | -4.58 Million AUD | 28.79% |
| 2019 Q2 | -3.22 Million AUD | 0.0% |
| 2019 Q4 | -3.32 Million AUD | 0.0% |
| 2018 FY | -6.44 Million AUD | 55.95% |
| 2018 Q4 | -1.62 Million AUD | 0.0% |
| 2018 Q2 | -4.82 Million AUD | 0.0% |
| 2017 FY | -14.62 Million AUD | 12.92% |
| 2017 Q2 | -9.31 Million AUD | 0.0% |
| 2017 Q4 | -5.3 Million AUD | 0.0% |
| 2016 FY | -16.79 Million AUD | -23419.44% |
| 2016 Q4 | -17.07 Million AUD | 0.0% |
| 2016 Q2 | 282 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 FY | 72 Thousand AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q2 | 72 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -63.097% |
| Adherium Limited | -640.83 Thousand AUD | 995.238% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 89.374% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -299.316% |
| Anteris Technologies Ltd | 2.51 Million AUD | -127.914% |
| Control Bionics Limited | 3.67 Million AUD | -56.203% |
| CardieX Limited | 10.1 Million AUD | 43.242% |
| Compumedics Limited | 26.06 Million AUD | 77.992% |
| Cochlear Limited | 1.69 Billion AUD | 99.662% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 49.495% |
| Cyclopharm Limited | 4.49 Million AUD | -27.565% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 48.864% |
| Nova Eye Medical Limited | 20.19 Million AUD | 71.589% |
| HeraMED Limited | -504.09 Thousand AUD | 1238.079% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 387.873% |
| ImpediMed Limited | 9 Million AUD | 36.291% |
| InhaleRx Limited | 1.2 Million AUD | -376.477% |
| LBT Innovations Limited | -2.91 Million AUD | 296.675% |
| Neurotech International Limited | -5867.00 AUD | 97884.217% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -10212.41% |
| PolyNovo Limited | 36.08 Million AUD | 84.101% |
| Respiri Limited | 456.91 Thousand AUD | -1155.597% |
| SomnoMed Limited | 55.13 Million AUD | 89.594% |
| Universal Biosensors, Inc. | 4.28 Million AUD | -33.888% |
| Uscom Limited | 3.11 Million AUD | -84.132% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 2216.068% |